glp 1 in heart failure GLP-1 receptor agonists and myocardial metabolism atrial fibrillation Glucagon-like peptide 1 receptor agonists:

In practical terms, low energy availability may contribute to: Slower muscle and tendon remodeling Reduced tolerance to training volume Delayed strength progression during rehabilitation Higher perceived fatigue Increased risk of overuse symptoms Longer timelines to return to sport at full performance capacity For physical therapists and sports medicine clinicians, this matters more than ever

Weight Loss Response to Semaglutide in Postmenopausal Women with and without Hormone Therapy Use. Menopause , vol

This is a fundamentally different strategy

The current product labels recommend stopping GLP-1 medications at least 2 months before pregnancy